Swiss National Bank
PASG icon

Swiss National Bank’s Passage Bio PASG Stock Holding History

Swiss National Bank’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,975
Closed -$184K – 2778
2022
Q1 		$184K Hold
2,975
– – ﹤0.01% 2681
2021
Q4 		$378K Buy
2,975
+290
+11% +$47.4K ﹤0.01% 2700
2021
Q3 		$535K Hold
2,685
– – ﹤0.01% 2576
2021
Q2 		$711K Hold
2,685
– – ﹤0.01% 2577
2021
Q1 		$939K Buy
2,685
+1,400
+109% +$598K ﹤0.01% 2366
2020
Q4 		$657K Sell
1,285
-250
-16% -$100K ﹤0.01% 2422
2020
Q3 		$402K Hold
1,535
– – ﹤0.01% 2391
2020
Q2 		$839K Buy
+1,535
New +$690K ﹤0.01% 2203

Other funds holding PASG

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swiss National Bank's PASG Position: Q2 2022 in Review

Swiss National Bank sold out of Passage Bio (PASG) in Q2 2022, closing a stake of 2,975 shares — an estimated $184K sold.

Swiss National Bank first reported a position in PASG in Q2 2020 and held it in 8 quarters. The position peaked at $939K in Q1 2021. 85 funds tracked by Wall St. Rank hold PASG as of Q2 2022.

  • Swiss National Bank reported no remaining Passage Bio position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 2,975 Passage Bio shares in Q2 2022, an estimated $184K.
  • Swiss National Bank first reported a position in Passage Bio in Q2 2020 and held it in 8 quarters.
  • Swiss National Bank's Passage Bio position peaked at $939K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Passage Bio as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.